Clinical Trial

Synbiotic Formula (SCV09) in Alzheimer's Disease Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
In recent years, emerging studies have revealed the role of gut microbiota in human health and diseases, including AD and other neurodegenerative conditions5. Although the underlying mechanism is still largely unknown, successful therapies targeting the gut-brain axis may serve as indirect evidence of the possible linkage. This pilot, single-arm study aims to estimate the efficacy and assess the safety profile of the use of a new synbiotic formula (SCV09) in improving dementia-related behaviour in Alzheimer's disease patients, paving the way for a large-scale randomised controlled trial in the future.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-28.
Status change: Not Yet Recruiting → Recruiting 2025-09-01
Trial Details
NCT Number NCT06948929
Lead Sponsor Chinese University of Hong Kong
Conditions Alzheimer Disease
Enrollment 30 participants
Start Date 2025-05-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-03